Does Medicaid cover Mounjaro?
Mounjaro's Medicaid answer rests on one fact: both of its indications are type 2 diabetes. That makes it a drug no state can exclude — and one no state has to cover for weight, because the weight label for tirzepatide belongs to Zepbound.
Does Medicaid cover Mounjaro?
Yes for type 2 diabetes, in adults and in children 10 and older: the statute lets a state exclude weight-loss drugs, not diabetes drugs, so a state can only manage Mounjaro with its preferred-drug list and prior authorization. For weight, no — the tirzepatide approved for weight is Zepbound. 11 of 51 state programs cover a GLP-1 for obesity at all, and the documents of 1 of them mention Mounjaro by name — set out below, because mentioning is not always covering.
Type 2 diabetes, including for children
Mounjaro's two indications are both in type 2 diabetes: glycemic control in adults and in children from 10, and reducing major cardiovascular events in adults with type 2 diabetes at high risk of them. Neither is weight loss, so the statute's exclusion does not apply, and a state can manage Mounjaro only through its preferred-drug list and prior authorization.
For children the federal floor is higher still. Under EPSDT, Medicaid must cover what is medically necessary for a member under 21, whatever the state's adult rules say — so for a child with type 2 diabetes, the pediatric indication is a coverage question the state cannot close.
A preferred-drug list can still put another GLP-1 first. For someone stable on Mounjaro, the prior authorization is where the prescriber records why switching would be the wrong call.
Read from FDA prescribing information for MOUNJARO, via DailyMed and Social Security Act §1927(d)(2).
What each state's document says about Mounjaro
What this site recorded for 1 of the 51 programs names Mounjaro. Each line is from what this site recorded for that state, read from the document linked under it — covering states first.
MissouriCovered, with prior authorization for obesity
- Mounjaro needs a written medical reason why Zepbound cannot be used.
MO HealthNet GLP-1 Receptor Agonists for All Indications prior authorization form, dated 2024-10-01; read 2026-09-10.
For weight, the states that cover this molecule name Zepbound, its weight-labeled sibling. Medicaid and Zepbound, state by state →
The card, and the cash price
The maker's savings card is not an option on Medicaid. Every manufacturer excludes government beneficiaries, because federal anti-kickback rules bar a maker from subsidizing a federal program's copay. If your state says no and you pay cash, Mounjaro is $499 a month once titrated, read from its own published page on 2026-09-11.
If Medicaid says no
Federal Medicaid law requires an answer to a drug prior authorization within 24 hours, and a 72-hour emergency supply while it is pending. In a managed care plan you have 60 days from a denial to appeal to the plan, which must decide within 30 days, or 72 hours if it is urgent. On a decision the state makes itself, it may allow up to 90 days to ask for a fair hearing. Social Security Act §1927(d)(5); 42 CFR 438.402; 42 CFR 438.408; 42 CFR 431.221
What a Mounjaro request has to show → The appeal letter builder fills in your state's own criteria and the fair-hearing rules.
Medicaid and Mounjaro, answered
- Does Medicaid cover Mounjaro?
- For type 2 diabetes, yes in every state, for adults and for children 10 and older, where EPSDT also applies. A state can require prior authorization or a preferred GLP-1 first.
- Does Medicaid cover Mounjaro for weight loss?
- It is not on Mounjaro's label, so no state has to. The tirzepatide states cover for obesity, where they cover it at all, is Zepbound.
- Will Medicaid switch me from Mounjaro to another GLP-1?
- It can make another one the preferred product and ask you to try it first; it cannot drop diabetes coverage of the class. If you are stable on Mounjaro, the prior authorization is where your prescriber documents why switching would be wrong.